STOCKHOLM, Sept. 23, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has received the initial order for a clinical study under the collaboration with Castle Biosciences. The...
Hence then, the article about scibase receives initial order for clinical study from castle biosciences was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SciBase receives initial order for clinical study from Castle Biosciences )
Also on site :
- Kentucky congressman announces death of longtime staffer, campaign manager
- The Christmas Day Storm
- Camarillo man arrested after stolen camera reactivated and installed on the exterior of a home